Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kv1.3 is a voltage-gated potassium channel belonging to the shaker-related subfamily of potassium channels. It is encoded by the KCNA3 gene in humans. Kv1.3 channels are integral membrane proteins that selectively permit K+ ions to flow out of cells in response to changes in membrane potential. Elevated expression or activity of Kv1.3 has been linked to several diseases and it has become an attractive drug target.
Channel gating involves movement of S4 helix upon depolarization leading to opening/closing via displacement at S4-S5 linker region. Cytoplasmic domains mediate assembly/regulation/inactivation via protein-protein interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium voltage-gated channel subfamily A member 3 (Kv1.3).